Quick Hits: Fish Oil Doesn’t Help Asthma, E-Cigs and Heart Disease & More

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

Fish oil doesn’t help improve uncontrolled asthma in adolescents and young adults who are overweight or obese. Researchers recruited overweight or obese participants between the ages of 12 and 25 who had poor asthma control despite using a daily inhaled corticosteroid. Some of the participants took fish oil daily for 25 weeks and the others took a placebo pill with soy oil. Researchers theorized that because omega-3 fatty acids have anti-inflammatory properties, fish oil pills might ease asthma. However, there was no difference in asthma symptom reduction between the two groups. Posted January 25, 2019. Via the Annals of the American Thoracic Society.

People who use e-cigarettes or vaping devices have a higher rate of heart attack, heart disease and stroke. Researchers analyzed results from the 2016 Behavioral Risk Factor Surveillance System, a phone survey. More than 400,000 people responded, of whom almost 67,000 reported using an e-cigarette at least once. E-cigarette users had a 59% higher risk of heart attack, 40% higher risk of heart disease and 71% higher risk of stroke compared to those who didn’t use e-cigs. The results have yet to be published in a peer-reviewed scientific journal, but will be presented at the American Stroke Association’s International Stroke Conference on February 6. Posted January 30, 2019. Via American Stroke Association.

A company that manufactures a male sexual enhancement supplement is recalling some of its product because it contains prescription erectile dysfunction medication. The product is Silver Bullet 10x, manufactured by Nature’s Rx. The FDA says that the product, which is sold online, contains sildenafil and tadalafil, which are, respectively, the active ingredients in Viagra and Cialis. Some of the ingredients in Silver Bullet 10x include horny goat weed, icariin and ginger root. Posted January 29, 2019. Via FDA.

Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.

Did you find this article helpful?

Latest News

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement